Sponsors need to be realistic about price and commit incremental equity on top of a 100% rollover to stand out in today’s market, says Andrew Gulotta, a partner at Sixpoint Partners.
Linden Capital Partners on why healthcare CVs are gaining traction
1 October 2026 · 5 mins read
McDermott on preparing for exit in a selective M&A market
21 September 2026 · 5 mins read
Taproot Capital on understanding the seeding opportunity for spin-outs
14 September 2026 · 6 mins read
Simpson Thacher & Bartlett on how buyside expansion fuels dealflow
1 June 2026 · 7 mins read
W Capital Partners on why secondaries is now core to PE portfolio management
1 June 2026 · 5 mins read
Fried Frank on the next step for CVs
1 June 2026 · 8 mins read
Dawson Partners on predicting a $300bn year for secondaries
1 June 2026 · 5 mins read
